Xenetic
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xenetic and other ETFs, options, and stocks.About XBIO
Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen.
CEOJames F. Parslow
CEOJames F. Parslow
Employees2
Employees2
HeadquartersFramingham, Massachusetts
HeadquartersFramingham, Massachusetts
Founded2011
Founded2011
Employees2
Employees2
XBIO Key Statistics
Market cap4.53M
Market cap4.53M
Price-Earnings ratio-1.01
Price-Earnings ratio-1.01
Dividend yield—
Dividend yield—
Average volume41.36K
Average volume41.36K
High today$2.10
High today$2.10
Low today$1.91
Low today$1.91
Open price$2.04
Open price$2.04
Volume54.74K
Volume54.74K
52 Week high$13.93
52 Week high$13.93
52 Week low$1.90
52 Week low$1.90
Stock Snapshot
The current Xenetic(XBIO) stock price is $1.95, with a market capitalization of 4.53M. The stock trades at a price-to-earnings (P/E) ratio of -1.01.
During the trading session on 2025-12-17, Xenetic(XBIO) shares reached a daily high of $2.10 and a low of $1.91. At a current price of $1.95, the stock is +2.2% higher than the low and still -7.0% under the high.
Trading volume for Xenetic(XBIO) stock has reached 54.74K, versus its average volume of 41.36K.
The stock's 52-week range extends from a low of $1.90 to a high of $13.93.
The stock's 52-week range extends from a low of $1.90 to a high of $13.93.
People also own
Based on the portfolios of people who own XBIO. This list is generated using Robinhood data, and it’s not a recommendation.